Although there have been no major innovations for the treatment of hypothyroidism since the 1970s, when thyroid extract was superseded by LT4, a synthetic L form of tetraiodothyronine, the knowledge about the pathophysiology of thyroid disorders and their systemic impact has greatly improved. This has led to new indications for LT4 treatment and to changes in clinical practice for the diagnosis and management of both clinical and subclinical hypothyroidism. Therefore, the standards of care in thyroidology need to be constantly updated and disseminated. This program aims to raise awareness about the systemic impact of hypothyroidism, even at the subclinical stage, focusing on novel aspects such as the relationship between thyroid homeostasis and cognitive, cardiac and gonadal function, as well as to disseminate to most updated recommendations from international scientific societies.
Maddaloni Ernesto
